Simeon-Dubach Daniel, Kozlakidis Zisis, Tayal Juhi, McCall Shannon J, Hasan Wohaib, Betsou Fay, Lawson Jonathan, Allen Dominic
Medservice, Walchwil, Switzerland.
Laboratory Service and Biobank Group, International Agency for Research on Cancer, Lyon, France.
Biopreserv Biobank. 2024 Dec;22(6):557-562. doi: 10.1089/bio.2024.0153. Epub 2024 Dec 5.
While the FAIR (Findable, Accessible, Interoperable, and Reusable) principles are primarily concerned with data, samples can also be considered a distinct category of data. In light of these considerations, the FAIR principles represent a major challenge for biobanks, as discussed in detail in two recently published studies. We invited seven experts with diverse backgrounds to share their views on these studies and the FAIR principles in general. The contributions are written from different perspectives, including those from human biobanks operating globally, located in low- or middle-income countries or in high-income countries, as well as those from industrial or environmental biobanks. The last two contributions focused on technical feasibility and the necessary incentives. All authors agreed that while the FAIR principles present a challenge for biobanks, they also offer opportunities. Various useful instruments already exist, and more will follow. The key is to provide meaningful incentives.
虽然FAIR(可查找、可访问、可互操作和可重用)原则主要关注数据,但样本也可被视为一类独特的数据。鉴于这些考虑因素,正如最近发表的两项研究所详细讨论的那样,FAIR原则对生物样本库构成了重大挑战。我们邀请了七位背景各异的专家分享他们对这些研究以及FAIR原则总体情况的看法。这些稿件是从不同角度撰写的,包括来自全球运营的人类生物样本库、位于低收入或中等收入国家或高收入国家的样本库,以及来自工业或环境生物样本库的观点。最后两篇稿件聚焦于技术可行性和必要的激励措施。所有作者都认为,虽然FAIR原则给生物样本库带来了挑战,但也提供了机遇。各种有用的工具已经存在,而且还会有更多。关键是要提供有意义的激励措施。